Allergy Therapeutics (AGY) RNS Announcements

Add to Alert list
Date Time Source Announcement
16 Jul 2018 08:53 AM
RNS
BLOCK LISTING SIX MONTHLY RETURN
13 Jul 2018 09:40 AM
EQS
Allergy Therapeutics (AGY): Steady performance ...
12 Jul 2018 07:00 AM
RNS
Trading Update
25 Jun 2018 07:52 AM
RNS
Positive data of Pollinex Quattro Grass vaccine
29 May 2018 07:00 AM
RNS
Positive data with house-dust mite immunotherapy
21 May 2018 12:25 PM
EQS
Allergy Therapeutics (AGY): Opening the door to...
21 May 2018 07:00 AM
RNS
Positive top-line results from Grass Ph II study
14 May 2018 07:00 AM
RNS
Publication of MCT Adjuvant Data
16 Mar 2018 03:38 PM
RNS
Grant of Awards under Long Term Incentive Plan
16 Mar 2018 12:53 PM
RNS
Director/PDMR Shareholding
07 Mar 2018 09:30 AM
RNS
Hardman: Clinical development towards submission
07 Mar 2018 07:00 AM
RNS
Interim Results
28 Feb 2018 07:00 AM
RNS
Polyvac® Peanut CMO appointed
12 Feb 2018 07:00 AM
RNS
Completion of recruitment in PQ Grass Ph II trial
02 Feb 2018 07:15 AM
RNS
Hardman Research: Growth in a tough market
31 Jan 2018 07:00 AM
RNS
Trading Update
10 Jan 2018 03:19 PM
RNS
Holdings in Company
09 Jan 2018 07:00 AM
RNS
PQ Birch Phase III trial completes recruitment
12 Dec 2017 07:00 AM
RNS
Co-development agreement with Ergomed plc
07 Dec 2017 05:08 PM
RNS
Holding(s) in Company
22 Nov 2017 11:36 AM
RNS
Result of AGM
21 Nov 2017 07:00 AM
RNS
Block Listing Application
13 Nov 2017 07:00 AM
RNS
Allergy Therapeutics to Present at Jefferies 2017
07 Nov 2017 12:59 PM
RNS
Director/PDMR Shareholding
07 Nov 2017 11:54 AM
RNS
Director/PDMR Shareholding
19 Oct 2017 04:14 PM
RNS
Publication of Annual Report and notice of AGM
19 Oct 2017 07:00 AM
RNS
Commencement of dosing in PQ Grass Phase II Trial
12 Oct 2017 05:39 PM
RNS
Holding(s) in Company
12 Oct 2017 02:55 PM
RNS
Director/PDMR Shareholding
10 Oct 2017 07:15 AM
RNS
Hardman Research: Continuing to gain market share
28 Sep 2017 07:00 AM
RNS
Preliminary Results
18 Sep 2017 07:00 AM
RNS
Approval for PQ Grass Phase II trial
11 Sep 2017 07:00 AM
RNS
Expansion of Clinical Development and R&D teams
15 Aug 2017 07:00 AM
RNS
Notice of Results
18 Jul 2017 07:00 AM
RNS
Trading Update
06 Jul 2017 07:00 AM
RNS
Publication of adjuvant studies in journals
27 Jun 2017 07:00 AM
RNS
Investor and analyst site visits
19 Jun 2017 07:00 AM
RNS
Satellite Symposium at EAACI 2017
06 Jun 2017 07:00 AM
RNS
Directorate changes
02 Jun 2017 12:55 PM
RNS
Holding(s) in Company
13 Apr 2017 07:00 AM
RNS
Issue of Equity
05 Apr 2017 07:15 AM
RNS
Hardman Research: Development across portfolio
29 Mar 2017 07:00 AM
RNS
Interim Results for six months ended 31 Dec 2016
16 Mar 2017 07:00 AM
RNS
First Patient in Pivotal Phase III Birch Study
09 Mar 2017 07:00 AM
RNS
Notice of Interim Results
14 Feb 2017 07:00 AM
RNS
House Dust Mite Allergy Vaccine Gains CTA Approval
08 Feb 2017 07:00 AM
RNS
Directorate Change
01 Feb 2017 07:00 AM
RNS
Positive Efficacy & Safety Data in Peanut Vaccine
20 Jan 2017 07:15 AM
RNS
Hardman Research: Investment driving market share
19 Jan 2017 07:00 AM
RNS
Trading Update
UK 100

Latest directors dealings